radiance-htn trio: key takeaways and implications for the treatment of hypertension - europcr 2021
Published 3 years ago • 774 plays • Length 10:17Download video MP4
Download video MP3
Similar videos
-
9:18
radiance-htn-trio: what does this mean for the treatment of hypertension? - europcr 2021
-
45:12
redefining hypertension management with renal denervation - europcr 2021
-
13:20
the radiance htn-solo results - a sound choice for renal denervation
-
40:40
how does paradise renal denervation fit into hypertension treatment management? - europcr 2021
-
38:23
a review of the radiance-htn global clinical trial programme: a focus on the trio cohort - #europcr
-
5:30
hypertension management in 2022: latest data on renal denervation from #europcr 2022
-
13:02
radiance-htn trio - primary analysis and result
-
59:05
radiance-htn solo: primary outcomes of renal denervation - session webcast
-
5:50
radiance signals a bright future for renal denervation - europcr 2018
-
10:34
renal denervation based therapies for hypertension - europcr 2018
-
59:03
renal denervation for treatment of hypertension – heading for new shores - webinar
-
16:21
acc 2021 discussion: the randomized sham-controlled radiance-htn trio trial
-
7:21
renal denervation for hypertension treatment: what have we learnt recently?
-
10:17
ultrasound renal denervation with dr. sharp at europcr 2021
-
1:00:18
innovations in device-based treatment for hypertension - europcr 2023
-
59:54
from proof to practice - treating hypertension with ultrasound renal denervation - europcr 2023
-
6:38
europcr 2018 highlights - interventions for hypertension
-
1:00:59
advancing the treatment of uncontrolled hypertension with ultrasound renal denervation - europcr2022
-
6:21
clinical event reductions at 3 yrs in high-risk hypertension patients treated with rd - europcr 2021